Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Clinical Trials
Return to: PBR Home | Contract Research & Services | Clinical Trials
Search Refinements
Search Results: Clinical Trials
1-15 of 4966 results
FDA places clinical hold on Concert Pharmaceuticals’ hair loss drug
The US Food and Drug Administration (FDA) has placed a clinical hold on Concert Pharmaceuticals’ CTP-543 Phase 2a clinical trial for alopecia areata.
Contract Research & Services > Clinical Trials > News
Shire’s swelling disorder drug meets primary and secondary endpoints in phase 3 study
By PBR Staff Writer
Shire’s swelling disorder treatment, lanadelumab, has met its primary endpoint and all secondary endpoints in a phase 3 study.
Contract Research & Services > Clinical Trials > News
ImmunoGen unveils promising data with mirvetuximab soravtansine in ovarian cancer
ImmunoGen has reported promising safety and efficacy data from monotherapy and combination trials with mirvetuximab soravtansine in patients with folate receptor alpha (FRα)-positive epithelial ovarian cancer (EOC).
Contract Research & Services > Clinical Trials > News
Aduro Biotech expands clinical collaboration with Merck
Aduro Biotech has expanded its clinical collaboration with Merck to include an additional Phase 2 clinical trial.
Contract Research & Services > Clinical Trials > News
Nutraceutical product line with Unigel technology
Excellence in Fixed Dose Combinations for Prevention & Nutrition
Contract Research & Services > Clinical Trials > Case Studies
Summit completes patient enrollment in phase 2 trial of ezutromid in DMD
Summit Therapeutics has completed enrolment in PhaseOut DMD, a phase 2 proof of concept clinical trial of ezutromid, in Duchenne muscular dystrophy (DMD) patients.
Contract Research & Services > Clinical Trials > News
Ardelyx reports positive results from phase 3 trial of Tenapanor in IBS-C patients
Ardelyx reported positive, topline results from the T3MPO-1 trial, the first of two Phase 3 trials evaluating tenapanor for the treatment of patients with irritable bowel syndrome with constipation (IBS-C).
Contract Research & Services > Clinical Trials > News
Lilly’s migraine drug galcanezumab succeeds in three phase 3 studies
Eli Lilly's galcanezumab has met its primary endpoint in three phase 3 studies (EVOLVE-1, EVOLVE-2 and REGAIN) showing statistically significant reductions in the number of monthly migraine headache days against placebo at both studied doses.
Contract Research & Services > Clinical Trials > News
AstraZeneca’s Imfinzi meets primary endpoint in phase 3 NSCLC trial
By PBR Staff Writer
AstraZeneca’s Imfinzi (durvalumab) has significantly reduced the risk of disease worsening or death in patients with third stage lung cancer in a phase 3 trial.
Contract Research & Services > Clinical Trials > News
Roche’s advanced bladder cancer drug Tecentriq fails in phase 3 trial
Roche’s phase III IMvigor211 study of Tecentriq (atezolizumab) in people with locally advanced or metastatic urothelial cancer (mUC) whose disease progressed during or after treatment with a platinum-based chemotherapy (previously treated) has failed to meet its primary endpoint of overall survival (OS) compared to chemotherapy.
Contract Research & Services > Clinical Trials > News
Array, Merck to evaluate binimetinib-Keytruda combination for colorectal cancer
Array BioPharma and Merck have entered into a clinical trial collaboration agreement to investigate the safety and efficacy of the former’s MEK inhibitor, binimetinib, with Merck's anti-PD-1 therapy, Keytruda (pembrolizumab), in metastatic colorectal cancer patients with microsatellite stable tumors (MSS CRC).
Contract Research & Services > Clinical Trials > News
Daiichi Sankyo initiates phase 3b study of Lixiana
Daiichi Sankyo announced the initiation of the ENVISAGE-TAVI AF study of Lixiana by enrolling the first patient in the trial.
Contract Research & Services > Clinical Trials > News
Myovant’s hormonal therapy relugolix succeeds in phase 2 trial
Myovant Sciences has reported positive results from a placebo-controlled Phase 2 dose-finding trial evaluating the ability of relugolix to decrease heavy menstrual bleeding in women with uterine fibroids which was conducted by Takeda Pharmaceutical in Japan.
Contract Research & Services > Clinical Trials > News
Relvar Ellipta improves asthma control in Salford Lung Study
GlaxoSmithKline and Innoviva said that their asthma drug Relvar Ellipta yielded positive results from the Salford Lung Study (SLS) in 4,233 asthma patients treated by their own general practitioner in everyday clinical practice.
Contract Research & Services > Clinical Trials > News

PBR Supplier Recommendations

CTL Laboratories - Contract Immune Monitoring and Research
Cellular Technology Limited (CTL), headquartered in Shaker Heights, OH, is a privately held biotechnology company that built its reputation as the global leader in the ELISPOT field over the past two decades by establishing the ELISPOT instrumentation and scientific principles that have helped to define the parameters of ELISPOT research for monitoring of Cell-Mediated Immunity.... Contract Research & Services > Clinical Trials > Suppliers
CRFweb... from Clindox, Suppliers of Clinical Trial Software
CRFweb is the groundbreaking eCRF application brought to you by Clindox. It sets new standards in web-based, clinical trial software. The combination of a comprehensive feature set, incredibly quick set-up time, simplicity of use and flexible pricing means no trial is too large or too small to be practical. The whole process is genuinely DIY, allowing trial managers to really take control of their trial. ... Contract Research & Services > Clinical Trials > Suppliers
LABORATORIOS INIBSA - Pharmaceutical Contract Manufacturing Company
LABORATORIOS INIBSA is a pharmaceutical contract manufacturing company. We have more than 60 years' experience and belong to the INIBSA GROUP. INIBISA supplies products and services to Biotools, Inibsa Dental and Inibsa Hospital, as well as other pharmaceutical companies through our contract manufacturing division. From our facilities in Lliçà de Vall, 20km from Barcelona LABORATORIOS INIBSA currently supplies more than 50 countries worldwide.... Contract Research & Services > Clinical Trials > Suppliers
Vaisala - Supplier of Continuous Monitoring Systems for Controlled Life Science Environments
Vaisala is a world leader in environmental and industrial measurement systems and instrumentation. We offer measurement instrumentation, continuous monitoring systems and validation systems to measure and supervise environmental conditions, within regulated or controlled life science environments.... Contract Research & Services > Clinical Trials > Suppliers
Quintiles - Bringing People and Knowledge Together for a Healthier World
Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment.... Contract Research & Services > Clinical Trials > Suppliers
See more

PBR White Paper Recommendations

Softigel introduces new energy gummies at vitafoods By Softigel pbr
Who hasn´t needed a wake-me-up in the morning or hasn´t dragged a tired body to the end of the day? Regardless how we individually spend our day, the intensity of our routine, the sports practice or the stressful of our labor; the common consequence is the high demand and lack of energy.... Contract Research & Services > Clinical Trials > White Papers A Survival Guide to Temperature Data in Life Sciences, by Almac By Almac
Regulations continue to evolve globally within the distribution arena of the Life Sciences industry. Good Distribution Practice of Medicinal Products for Human Use (2013/C 343/01)1 as well as Good Distribution Practices Supply Chain Integrity2 has made the most significant impact. There is an increased focus on companies being able to prove the quality and integrity of their drug product throughout the entire supply chain. The industry is facing stricter compliance demands from regulations and regulatory agencies are not always given clear guidance.... Contract Research & Services > Clinical Trials > White Papers Almac: Changing the Dynamics of Temperature Controlled Shipping Solutions By Almac
In the typical clinical trial today, the cost of shipping and distributing supplies accounts for approximately 60 percent of the overall clinical supply chain. And when the cost of product spoilage from temperature excursions is added into the mix, it is no wonder that pharmaceutical companies, Clinical Research Organizations (CROs), and logistics vendors are all eagerly searching for efficiencies and ways to carve costs out of the process.... Contract Research & Services > Clinical Trials > White Papers Almac Explores Interactive Response Technology: An Untapped Source of Historical and Real-Time Data for Risk-Based Monitoring By Almac
Risk-based monitoring has attracted the support of a diverse group of organisations in recent years. Regulators have released guidance encouraging the use of risk-based approaches to clinical trial quality, vendors have created technologies to support such methods, and large pharma companies have pooled their resources to drive adoption. Yet, despite this flurry of activity, the industry has overlooked a potentially useful source of real-time and historical data.... Contract Research & Services > Clinical Trials > White Papers Almac Presents Modern Perspectives on Peptide Synthesis, an Introduction By Almac
The complexity of synthetic peptide products, whether as reagents used in research or as therapeutic APIs, is increasing. As researchers understand more about the biochemical systems which are targeted, and invent ever more sophisticated products, manufacturing methods must keep pace. We look in this article at a number of challenging product classes, the specific problems they present, and potential solutions: Long peptides; Multi-peptide cocktails; Site-specifically modified products.... Contract Research & Services > Clinical Trials > White Papers See more
1-15 of 4966 results